Welcome to our dedicated page for Nordson SEC filings (Ticker: NDSN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Nordson Corporation filings document the formal disclosure record for an Ohio precision technology manufacturer with common shares listed on Nasdaq under NDSN. The company’s 8-K reports cover quarterly operating results, Regulation FD earnings commentary, shareholder vote outcomes, capital allocation authorizations, executive officer changes, compensation arrangements, and material financing agreements.
Recent filings include annual meeting results, proxy governance matters, an executive severance policy, a chief accounting officer transition, and an amended senior unsecured multicurrency revolving credit agreement involving Nordson and a German subsidiary. The record also identifies the company’s registered common shares and recurring disclosure areas tied to governance, liquidity, capital structure, and financial reporting.
Nordson Corporation reported solid growth for the quarter and first half of fiscal 2026. For the three months ended April 30, 2026, sales were $740.8 million, up 8.5% from a year ago, with net income of $117.3 million and diluted EPS of $2.09. Operating profit rose 16.9% as all three segments grew, led by Advanced Technology Solutions and Medical and Fluid Solutions, while gross margin stayed around 55%.
For the first six months, sales reached $1.41 billion, up 8.6%, and net income increased 21.1% to $250.7 million, or $4.47 per diluted share. Interest expense declined on lower average debt, and other income benefited from gains on a minority investment, partly offset by a $24.0 million U.S. pension settlement loss. Operating cash flow was strong at $321.1 million, supporting $107 million of debt repayment, $129.3 million of share repurchases, and $91.6 million of dividends, while maintaining access to a $1.2 billion revolving credit facility.
Nordson Corporation reported record second quarter fiscal 2026 results and raised its full year outlook. Sales reached a second quarter record of $741 million, up 8% from $683 million a year earlier, driven by 7% organic growth and a 3% favorable currency impact, partly offset by a divestiture and a small acquisition.
Net income was $117 million, or $2.09 diluted EPS, compared with $112 million, or $1.97 per diluted share. Results included a one-time non-cash pension settlement charge and a non-cash loss on minority investments. Excluding these items and acquisition-related costs, adjusted diluted EPS reached a record $2.86, up 18% from $2.42.
EBITDA was also a second quarter record at $235 million, or 32% of sales, up from $217 million. All three segments delivered record or higher second quarter sales, and backlog increased 18% year-over-year, supporting stronger demand. For the third quarter, the company forecasts sales of $760–$790 million and adjusted diluted EPS of $2.95–$3.15. For the full fiscal year, Nordson now expects sales of $2.93–$3.01 billion and adjusted diluted EPS of $11.30–$11.80, reflecting confidence in ongoing momentum across its end markets.
Nordson Corp director Anette K. Clayton acquired company shares through equity awards and deferred compensation. On November 1, 2025 she was granted 822 restricted share units that were scheduled to vest on October 31, 2026. When her Board service ended on March 1, 2026, 552 units were forfeited and 270 remaining units were deferred into share-equivalent units.
On May 1, 2026, 2,098 stock equivalent units in her deferred compensation account converted into common shares on a one-for-one basis and were distributed to her. The Form 4 records 270 directly owned shares at a reference price of $283.20 per share and a total of 2,098 shares following the reported transaction.
Nordson Corp director John A. DeFord reported an acquisition of company equity through compensation. On the reported date, he received 87 shares of NDSN at a reference value of $288.45 per share as a grant/award, bringing his direct holdings to 5,802 shares.
Footnotes explain that he elected to defer his quarterly cash retainer into Stock Equivalent Units under the Directors' Deferred Compensation Sub-Plan, which convert into common shares on a one-for-one basis at distribution. His total holdings also include 18 Stock Equivalent Units and/or Restricted Share Units accrued from dividend payments under the company’s Stock Incentive and Award Plan.
Nordson Corp director Christopher L. Mapes acquired 43 stock equivalent units of NDSN on a compensation-related basis. The units were valued at $288.45 per share and resulted from his election to defer a portion of his quarterly cash retainer into stock equivalent units under the company’s Directors' Deferred Compensation Sub-Plan.
After this grant, he directly holds 2,975 NDSN shares, which include 9 stock equivalent units and/or restricted share units accrued from dividend payments under Nordson’s Stock Incentive and Award Plan. This filing reflects a routine grant/award acquisition rather than an open-market purchase.
Nordson Corp reports that Vanguard Capital Management disclosed beneficial ownership of 3,903,573 shares of Common Stock, representing 6.99% of the class.
The filing states Vanguard Capital Management exercises sole dispositive power over 3,903,573 shares and sole voting power over 456,882 shares. Ownership is reported on behalf of Vanguard funds and managed accounts.
Nordson Corp Executive Vice President James E. DeVries reported routine equity-related dispositions tied to retirement and prior gifts of company stock. On April 16, 2026, restricted share units granted in 2023 and 2024 fully vested upon his retirement, and a total of 198 NDSN shares (127 and 71 shares) were withheld at $275.28 per share to cover withholding taxes.
The filing also reports a previously unreported bona fide gift of 1,247 NDSN shares made earlier, which is being disclosed as part of his final Section 16 filing following retirement. DeVries continues to hold direct NDSN shares and multiple stock option awards with exercise prices between $107.65 and $267.51, with expiration dates extending through 2034.
Nordson Corp Executive Vice President Srinivas Subramanian reported an exercise-and-sale transaction in company stock. He exercised stock options for 1,900 NDSN shares at $107.65 per share through a broker-assisted cashless exercise, with shares sold to pay the exercise price, withholding taxes, and related fees.
On the same date, he completed open-market sales totaling 3,100 shares at $280.00 per share, executed under a pre-arranged Rule 10b5-1 trading plan adopted on January 13, 2026. Separately, 1,615 shares are attributable to his participation in the company savings plan.
NDSN submitted a Form 144 notice reporting the proposed sale of 3,100 shares of Common Stock through Fidelity Brokerage Services LLC. The filing lists an aggregate amount of $868,000.00 and a filing/offer date of 04/17/2026. The excerpt also itemizes multiple restricted stock vesting lots and 1,900 shares tied to an option granted on 11/21/2016 with cash noted as consideration on 04/17/2026.
Nordson Corp director Morris Milton Mayo sold 245 NDSN shares in an open-market transaction at $273.87 per share. After this sale, he directly owned 2,656 shares. The transaction involved common stock (non-derivative) and was reported on a Form 4 insider filing.